UKBizDB.co.uk

PB DRUG DEVELOPMENT CONSULTANCY LTD

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Pb Drug Development Consultancy Ltd. The company was founded 16 years ago and was given the registration number 06830207. The firm's registered office is in CAMBRIDGE. You can find them at 122 Tenison Road, Cambridge, Cambridge, Cambs. This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:PB DRUG DEVELOPMENT CONSULTANCY LTD
Company Number:06830207
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:25 February 2009
End of financial year:28 February 2023
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:122 Tenison Road, Cambridge, Cambridge, Cambs, CB1 2DW
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
122, Tenison Road, Cambridge, United Kingdom, CB1 2DW

Director25 February 2009Active
122, Tenison Road, Cambridge, Cambridge, CB1 2DW

Director22 July 2015Active

People with Significant Control

Mr Peter Buchan
Notified on:06 February 2017
Status:Active
Date of birth:July 1950
Nationality:British
Address:122, Tenison Road, Cambridge, CB1 2DW
Nature of control:
  • Ownership of shares 25 to 50 percent
Ms Marina Aurora Montenegro
Notified on:06 February 2017
Status:Active
Date of birth:October 1974
Nationality:Italian
Address:122, Tenison Road, Cambridge, CB1 2DW
Nature of control:
  • Ownership of shares 25 to 50 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (3 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (5 months remaining)

Copyright © 2025. All rights reserved.